Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.42 |
| ▸ | PRKDC | P78527 | 5/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.35 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | TTR | P02766 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17036318 | 0.92 | ALOX5 (0.40) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL12206326 | 0.90 | ALOX5 (0.45) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL17036315 | 0.90 | ALOX5 (0.39) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL17036267 | 0.89 | ALOX5 (0.43) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL12206423 | 0.89 | ALOX5 (0.44) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL17036314 | 0.89 | ALOX5 (0.38) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL17036307 | 0.88 | ALOX5 (0.41) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL17036316 | 0.88 | ALOX5 (0.38) | ALOX5PRKDCGGPS1PTGES2ATM | |
| SCHEMBL17036284 | 0.86 | ALOX5 (0.40) | ALOX5PRKDCATMPGRPIK3CD | |
| SCHEMBL17036305 | 0.85 | ALOX5 (0.39) | ALOX5PRKDCGGPS1PIK3CDPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150243892-A1 | Organic Compound, Light-Emitting Element, Display Module, Lighting Module, Light-Emitting Device, Display Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-08-27 | — | — | US | disclosed |
| US-20150243892-A1 | Organic Compound, Light-Emitting Element, Display Module, Lighting Module, Light-Emitting Device, Display Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150243892-A1 | Organic Compound, Light-Emitting Element, Display Module, Lighting Module, Light-Emitting Device, Display Device, Electronic Device, and Lighting Device | ESR1, EHD1, DDT | ALOX5 1269/4885PRKDC 2644/4885GGPS1 2472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.